Back to results
US 2026/0083874 A1Published application
Haemostatic composition
AssigneeFerrosan Medical Devices A/S
InventorsPeter Lund Hammershøj, Vikram Kjøller Bhatia, Anca Gabriela Bejenariu, Urshan Abid, Camilla Arboe Jennum, Sylvia Natalie Klodzinska
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to haemostatic compositions comprising a biocompatible polymer, thrombin and fibrinogen and methods for the preparation of such compositions.
Claims54
A haemostatic composition comprising:
- a) a biocompatible polymer in particulate form, selected from gelatine, collagen, chitin, chitosan, alginate, cellulose, oxidised cellulose, carboxymethylcellulose, polyglycolic acid, polyacetic acid and combinations thereof,
- b) fibrinogen in an amount of 1 to 150 mg per gram of the biocompatible polymer, and
- c) thrombin in an amount of 100 to 5000 IU per gram of the biocompatible polymer.
(canceled)
A haemostatic composition comprising:
- a) a biocompatible polymer in particulate form in an amount of 7 to 34% by weight, wherein said biocompatible polymer is selected from gelatine, collagen, chitin, chitosan, alginate, cellulose, oxidised cellulose, carboxymethylcellulose, polyglycolic acid, polyacetic acid and combinations thereof;
- b) fibrinogen in an amount of 0.008 to 5% by weight,
- c) thrombin in an amount of 7 to 1700 IU per gram of the haemostatic composition, and
- d) an aqueous medium.
1 more element
Dependencies are inferred from the claim text.